MLchartDataset catalogue

DNA interference oligonucleotide PNT2258

Term · Oncology and biomedicine · MLC-T-ONC-013090

A liposomal formulation of the 24-mer oligonucleotide PNT100, with potential antineoplastic activity. PNT2258 targets and complements to untranscribed DNA sequence upstream of BCL2 promoters, thereby interfering with DNA replication and transcription of the BCL2 gene. This may promote and restore the apoptotic pathway in BCL2-overexpressing tumor cells. BCL2, an anti-apoptotic protein, is overexpressed in a wide variety of tumors.

Table 1. Record
IdentifierMLC-T-ONC-013090
FieldOncology and biomedicine
SynonymsDNA interference drug PNT2258
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013090",
  "term": "DNA interference oligonucleotide PNT2258",
  "field": "Oncology and biomedicine",
  "definition": "A liposomal formulation of the 24-mer oligonucleotide PNT100, with potential antineoplastic activity. PNT2258 targets and complements to untranscribed DNA sequence upstream of BCL2 promoters, thereby interfering with DNA replication and transcription of the BCL2 gene. This may promote and restore the apoptotic pathway in BCL2-overexpressing tumor cells. BCL2, an anti-apoptotic protein, is overexpressed in a wide variety of tumors.",
  "synonyms": [
    "DNA interference drug PNT2258"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/dna-interference-oligonucleotide-pnt2258/"
}

Record 6,104 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.